Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA

robot
Abstract generation in progress

Allspring Global Investments Holdings LLC significantly reduced its stake in ADMA Biologics Inc by 68.3% in Q4, selling over 1 million shares. Despite this, other hedge funds showed mixed activity, with some increasing and some initiating new positions. Insider transactions included a sale by the COO and a purchase by a director, while analysts maintain a “Buy” rating with an average target price of $32.00 after the company met EPS expectations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin